Navigation Links
Hypertensives could benefit regular alcohol consumption

A recent study reported by researchers in the Journal of Hypertension indicates that hypertensive patients could reduce their cardiovascular morbidity and improve their atherosclerotic risk profile by consuming alcohol on a regular basis. The researchers indicated that serum lipoprotein(a), a powerful predictor of organ damage, was reduced with regular alcohol consumption. The researchers studied 402 patients with untreated essential hypertension to assess the links between drinking// and serum lipoprotein(a) over a wide range of alcohol intake levels. They also investigated whether the association between alcohol intake and serum lipoprotein(a) concentrations occurred over the whole spectrum of apo(a) phenotypes.

The investigators found that there was no difference in lipoprotein(a) concentrations between teetotallers and occasional drinkers. However, they found that median lipoprotein(a) concentrations were 21% lower in light drinkers (those consuming up to 20 grams of ethanol daily), 26% lower in moderate drinkers (21-50 grams daily) and 57% lower in heavy drinkers (over 50 grams daily) when compared to teetotallers and occasional drinkers. These findings were similar to both men and women. They also studied the frequency distributions of apo(a) isoforms and liver function parameters and log lipoprotein(a) concentrations. They found that the former were comparable across these intake groups while the latter(log lipoprotein(a)) were inversely and independently correlated with alcohol consumption in hypertensives of both sexes.

Researchers concluded that lipoprotein(a) is inversely and dose-dependently related to alcohol intake in hypertensive patients, and that this relationship was independent of the size distribution of apo(a) isoforms.


'"/>




Page: 1

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Beware of the oral patch! It could be cancer!!!
3. Prozac miracle could end in disaster
4. Wonder drug - could end in disaster
5. Pollution could be a risk
6. Fright could be more harmful
7. Pregnant smokers could harm their child
8. Snoring could be a warning
9. Anthrax drug doxycycline could stunt fetal growth
10. Hike in drug licence fee could hit several SSI units in TN
11. Lengthy Fingers could predict heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... 2016 , ... 1105 Media’s Live From program has been ... competition. Live From won in the Use of Social Media category. The Folio: ... undertaken by the media industry’s most innovative marketing professionals. , Conceived ...
(Date:12/7/2016)... ... 2016 , ... Gensuite is honored to be selected as ... Product Launch category. Gensuite’s entry on their EZ Scan feature detailed the tool’s ... Training Group is a professional event and training provider based in the United ...
(Date:12/7/2016)... ... ... Road To Restoration”: an informative and enlightening book for those who believe that ... “The Road To Restoration” is the creation of published author, Thomas Fitzhugh Sheets, seventy-one-year-old ... you could reach out for, and grab, on the old carousels. If you ...
(Date:12/7/2016)... ... ... Rides a Train” allows readers to tag along on a special shopping trip for ... creation of published author, Janet Morrison, who has been writing mostly poetry, essays, professional ... series is her first attempt at writing for children. Janet, Fred, and two cats ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg ... the International Probiotic Association’s Washington DC workshop on November 2nd. The conference was ... dialog regarding probiotic dietary supplement regulations. , Dr. Leyer spoke about two ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016 According to responses from ... than one-third (38%) of patients with non-small cell lung cancer ... factor receptor (EGFR) genetic mutation status. The findings of the ... LBA ID #6067 #P3.02b ) at the 2016 World ... . The survey results revealed an overall ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 ... II trial in patients with unresectable malignant pleural ... survival (PFS). The data, presented at the 17 ... in Vienna , showed nintedanib ... to placebo plus pemetrexed/cisplatin, with a significantly improved ...
(Date:12/7/2016)... Today, Stock-Callers.com presents four Biotech equities ... ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ), ProNAi ... (NASDAQ: AVXS ). From its peak in July ... reach a level equal to what it saw at the ... for the year, it has still out-performed other market sectors, ...
Breaking Medicine Technology: